CD34 and acute myeloid leukemia: To conclude, primary AML cells and normal CD34+ bone marrow cells show complex differences in their proteomic profiles, and this complexity is further increased by additional variations between patient subsets with regard to post-translational modulation/phosphorylation for 16 of the 121 differentially abundant proteins.